Covid: Autoantibodies in severely ill patients could lead to a 'lifetime of trouble'

There are an estimated 18.5 million individuals at increased risk of developing severe Covid in the UK, due to underlying conditions. While vaccines have proven an effective shield against severe infection, waning antibodies could drive up hospital admissions in coming months.
A new study has found that autoantibodies, which are self-attacking proteins that are part of organs, immune defences or crucial signalling, are rife in patients battling severe symptoms of COVID-19.
The new study has suggested that about half of patients in hospital with COVID-19 develop dangerous immune system proteins that attack the body’s own tissue.
Researchers studied blood samples from almost 200 patients hospitalised in the early months of the pandemic.
Researchers identified signals in the patients’ blood samples that were similar to those in patients with other autoimmune conditions, including lupus, thyroid diseases and arthritis.
READ MORE: Staggering charts show true risk of not getting vaccinated – latest data


